BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260327
DTSTAMP:20260423T032146
CREATED:20260218T112126Z
LAST-MODIFIED:20260218T112126Z
UID:9911-1774224000-1774569599@thebiocalendar.com
SUMMARY:DCAT Week
DESCRIPTION:DCAT Week is the premier global event convening annually in New York City for companies engaged in the Bio/Pharmaceutical business ecosystem. It is hosted by the Drug\, Chemical & Associated Technologies Association (DCAT)\, a not-for-profit\, corporate member-supported\, global business development association whose unique membership model integrates both innovator and generic drug manufacturers with suppliers of ingredients\, development and manufacturing services\, and related technologies.
URL:https://thebiocalendar.com/event/dcat-week/
LOCATION:New York\, New York\, NY\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260324
DTEND;VALUE=DATE:20260327
DTSTAMP:20260423T032146
CREATED:20251212T172657Z
LAST-MODIFIED:20251212T172744Z
UID:9646-1774310400-1774569599@thebiocalendar.com
SUMMARY:Patients as Partners in Clinical Research
DESCRIPTION:13th Annual:\nDemonstrating HOW Patient Involvement\n​​​​​​​Gets Done to Enhance Access and Accelerate Medicine Development\n  \n\n\n\n\nPatients as Partners® in Clinical Research is the first conference dedicated to raising the patient voice in R&D to drive better clinical outcomes for all. Guided by a steering committee of Pharma R&D leaders\, the FDA\, patient advocates\, and engagement professionals\, the program is thoughtfully curated to deliver the latest insights\, strategies and case studies for implementing patient-centric approaches in drug development. \nThe event provides actual examples of progress and measurable value\, demonstrating how patient insights can drive efficiencies and improve outcomes. \nWe are thrilled to announce that the Patients as Partners in Clinical Research conference is now part of Fierce Life Sciences. Combining our resources allows for greater market reach\, more networking and partnering.
URL:https://thebiocalendar.com/event/patients-as-partners-in-clinical-research-4/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Forum,Networking
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260328
DTSTAMP:20260423T032146
CREATED:20260212T143153Z
LAST-MODIFIED:20260212T143234Z
UID:9898-1774396800-1774655999@thebiocalendar.com
SUMMARY:LSX World Congress Europe
DESCRIPTION:LSX World Europe (LSX Europe) is a leading life science fundraising and investment event\, bringing innovators and investors together through strategic 1:1 meetings and targeted networking. \nEarly-stage (Seed–Series B) biotech\, medical device\, diagnostics and digital health companies\, including university spin-outs – join to secure investment and build collaborations. \nActive life science investors attend\, looking for new investments and syndication. \nThrough our proven partnering format\, conversations turn into real partnerships and successful raises.
URL:https://thebiocalendar.com/event/lsx-world-congress-europe/
LOCATION:Lisbon\, Lisbon\, Portugal
CATEGORIES:Partnering
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260326T060000
DTEND;TZID=America/Los_Angeles:20260326T070000
DTSTAMP:20260423T032146
CREATED:20260310T161448Z
LAST-MODIFIED:20260310T161448Z
UID:9996-1774504800-1774508400@thebiocalendar.com
SUMMARY:2026 Manufacturing Trends Reshaping Life Sciences: AI\, Integration\, and Workforce Readiness
DESCRIPTION:Learn how leading manufacturers are connecting manufacturing\, quality\, and supply chain systems to improve visibility\, accelerate decision making and create more agile operations. The session will explore how organizations are strengthening supply chains and preparing their workforce for increasingly digital manufacturing environments.
URL:https://thebiocalendar.com/event/2026-manufacturing-trends-reshaping-life-sciences-ai-integration-and-workforce-readiness/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/03-26-26-MasterControl-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260326T080000
DTEND;TZID=America/Los_Angeles:20260326T170000
DTSTAMP:20260423T032146
CREATED:20260212T142522Z
LAST-MODIFIED:20260218T164505Z
UID:9896-1774512000-1774544400@thebiocalendar.com
SUMMARY:Charles River Cell & Gene Therapy Summit
DESCRIPTION:Returning to Boston this March \n\n\n\n\n\n\n\n\n\n\n\n\nConnect with Fellow Leaders Shaping Cell and Gene Therapy Development\n\n\n\n\n\n\n\n\n\n\n\n\n  \nThe eighth in a series of premier one-day events held in the world’s biggest biotech hubs\, Charles River is bringing together the leading experts\, executives\, and thought leaders in the CGT space to discuss and navigate critical challenges. \nRegister today to save your seat for an exclusive event aimed to inspire\, educate\, and connect you with the people shaping the future of advanced therapies.
URL:https://thebiocalendar.com/event/charles-river-cell-gene-therapy-summit/
LOCATION:Cambridge\, MA\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260326T130000
DTEND;TZID=America/Los_Angeles:20260326T140000
DTSTAMP:20260423T032146
CREATED:20260220T124433Z
LAST-MODIFIED:20260220T124433Z
UID:9943-1774530000-1774533600@thebiocalendar.com
SUMMARY:Avoiding Scale-Up Surprises: Applying AI and Rapid Prototyping to Media and Process Development
DESCRIPTION:As biologics grow more complex and development timelines continue to tighten\, many teams could encounter manufacturability challenges related to decisions around media\, process\, and scalability made earlier in development. Traditional\, sequential workflows may not always surface potential challenges until programs are already moving toward scale-up\, which can limit flexibility. \nIn this webinar\, Thermo Fisher Scientific experts discuss factors that contribute to manufacturability challenges during the transition from development to manufacturing. The session walks through a representative development journey\, including early insights from AI\, data modeling\, and analytical testing\, followed by media and process development\, qualification through rapid prototyping\, and considerations for large-scale cGMP manufacturing. \nDuring this session\, attendees will hear perspectives on how teams may:\n~ Consider manufacturability earlier in biologics development\n~ Inform development decisions with AI and data modeling\n~ Apply rapid prototyping to evaluate media and process choices\n~ Support development decisions prior to cGMP scale-up
URL:https://thebiocalendar.com/event/avoiding-scale-up-surprises-applying-ai-and-rapid-prototyping-to-media-and-process-development/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-26-26-Thermo-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260326T130000
DTEND;TZID=America/Los_Angeles:20260326T140000
DTSTAMP:20260423T032146
CREATED:20260224T125549Z
LAST-MODIFIED:20260224T125716Z
UID:9961-1774530000-1774533600@thebiocalendar.com
SUMMARY:Why Open-Source Models Matter for Computational Drug Discovery
DESCRIPTION:AI is reshaping every industry—and drug discovery is no exception. Across targets\, molecules\, and data at massive scale\, AI is becoming integral to how modern therapeutics are discovered and developed. \nThis panel explores how foundational open‑source AI engines like OpenFold and Boltz are being used across the drug discovery workflow\, from target discovery and validation to hit identification and lead optimization. Panelists will discuss the growing role of structural modeling\, chemoinformatics\, and predictive machine learning\, including how open models can enable faster structure–activity insights\, earlier toxicity prediction\, and more efficient decision‑making. The conversation will also touch on antibiotic discovery\, where AI is helping researchers break through long‑standing scientific and economic barriers by identifying new mechanisms\, molecular scaffolds\, and design strategies. \nThis session is designed for scientists and leaders seeking to understand where open-source AI is delivering real impact today—and why AI is no longer optional for staying competitive in drug discovery.
URL:https://thebiocalendar.com/event/why-open-source-models-matter-for-computational-drug-discovery/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/26_03-DDO-NL-468x60-1.png
END:VEVENT
END:VCALENDAR